News
InvestorsHub on MSN20m
SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement
SAB Biotherapeutics Inc (NASDAQ:SABS) saw its stock surge by 33% following the announcement of a $175 million private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback